Of six genes that were correspondingly differentially expressed between APL and each AML1 and AML2, three (CD3D, CD98, CD339) were higher expressed in APL, and three (CD52, CD62L, CD83) were higher in AML1/2. The gene discussed is SELL; the disease is acute promyelocytic leukemia.